North America Pregnancy Testing Market

North America Pregnancy Testing Market Size (2024 to 2032)

The size of the North American pregnancy testing market was worth USD 0.51 Billion in 2023. The North American market is estimated to reach USD 0.76 Billion by 2032 from USD 0.53 Billion in 2024, growing at a CAGR of 4.54% from 2024 to 2032.

Escalating first-time-age pregnancy, technological advancements, and rising levconsciousness els among the people regarding the various brands of pregnancy test kits to use for the tests are some of the major factors supporting the pregnancy testing market in North America.

Furthermore, hiking requirement levels for self-detecting kits, rising fertility disorders, and approving government proposals regarding family planning will further likely foster market growth in the coming years. In addition, using these pregnancy testing kits gives quick and accurate results in a digital format, another factor promoting the market's growth rate in this region.

In the past few years, there has been a rise in the incidence of unplanned pregnancies, dramatically leading to a high demand for pregnancy test kits and devices across North America. As published in the National Library of Medicine, an estimated 3 million unwanted pregnancies and 1.5 induced abortions are happening in the United States. In addition, growing awareness levels on the usage of pregnancy self-detection devices increased awareness of the benefits and advantages obtained by using these pregnancy detection kits, the rising rate of teenage pregnancy, the rise in government support for the use of pregnancy tests, and a high rise in demand for self-test pregnancy kits are further promoting the pregnancy testing market growth in North America. In addition, the rise in technological advancements in pregnancy test kits due to a constant trend in introducing new products in the market combined with manufacturers' focus on expanding distribution networks to increase device availability of more sensitive devices for improving consumer experience is further foreseen to fuel the market growth.

However, the high cost of pregnancy test kits and low adoption rates are significant challenges to market growth. Women with PCOS and having low ovulation use kits for ovulation expectations are likely to impede the market growth in North America. In the past decade, people have had less awareness regarding the availability of pregnancy testing kits and the risk of ineffective testing in some cases. Moreover, most of the kits claim to be 99% accurate, even though the possibility of attaining false results is high in some brands. Furthermore, strict government policies challenge industry players in the region. All these factors are expected to lead to a decline in the market's growth rate.

This research report on the North American pregnancy testing market has been segmented and sub-segmented into the following categories.

North America Pregnancy Testing Market - By Product

• Pregnancy Test Kits
• Strip Tests
• Midstream Kits
• Cassette Tests
• Digital Tests
• Fertility/Ovulation Tests
• Line Indicator Tests
• Digital Tests

North America Pregnancy Testing Market - By Test Type

• HCG Blood Test
• HCG Urine Test
• LH Urine Test
• FSH Urine Test

North America Pregnancy Testing Market - By Distribution Channel

• Hospitals & Specialty Clinics
• Pharmacies
• Online Retail
• Others (Supermarkets and Specialty Retail)

North America Pregnancy Testing Market - By Country

• The United States
• Canada
• Rest of North America

North America had the most significant share of the global market in 2023. The region's domination is expected in the global market throughout the forecast period.

Increased demand for self-testing kits due to increased awareness among women and technological advances to increase accuracy and decrease waiting time. High government spending on quality healthcare is favoring the market in North America. In addition, the high adoption of digital pregnancy test kits due to increasing disposable income, supportive government initiatives, and increased fertility disorders due to higher rates of unplanned pregnancies, leading to increased awareness of the use of pregnancy detection devices, are propelling the market growth. In addition, it has been observed that there is a higher proportion of working women or women in employment who rarely have time to consult a doctor except in an emergency. These testing devices are handy for such women's rapid and accurate functioning, supporting regional market growth.

The U.S. dominated the North American pregnancy testing market in 2022.

The presence of key market participants in the United States is primarily accelerating the growth rate of the market in the United States. In addition, the key market participants have shown interest in the United States to expand their business presence and gain momentum by focusing on joint promotions and joint marketing of their sophisticated products. This could be majorly due to many women being familiar with the latest technologies and the high incidence of unintended pregnancy. Also, in recent years, there has been a millennial baby boom in this country, far more than in other countries, which has led to an increase in the sale of rapid pregnancy and fertility test kits to confirm pregnancy that facilitate home pregnancy detection, along with First Response Early Result scenario and 99% accuracy. This might be the reason which is expected to drive the market in the United States during the forecast period.

KEY MARKET PLAYERS

A few of the notable companies operating in the North American pregnancy testing market are Abbott Laboratories, Cardinal Health, Church & Dwight, Germaine Laboratories, Kent Pharmaceuticals, Piramal Enterprises, Prestige Brands Holdings, Procter & Gamble Co., Quidel Corporation, SPD Swiss Precision Diagnostics.

RECENT HAPPENINGS IN THIS MARKET

• In December 2017, Lia Diagnostics Inc., an American Company, developed the first biodegradable pregnancy kits. The test will be available in the U.S. market in 2018.

• In March 2017, the failed batches of the Genesis Biotech PregSure digital test were the subject of an urgent recall. As a result, Minco Import and Export's One Step Pregnancy Test was removed from the registered sponsor, and the supply ceased.